| Human medicinal products | | | SPC PL |  | Veterinary medicinal
products | | SPC PL | | | Herbal medicinal products | | | SPC PL | | Name of the medicinal
product |
| | |
|
|
Package Leaflets (PL) for Human medicinal products
The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.
The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.
The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA.
Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website.
Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Product Information Leaflets 271 - 300 of 326 |
|
|
|
| SPC | Status for
supply | Name of the medicinal product |
|
|
|
European Medicines Agency's website:
Movymia - EMA: EPAR PI
Finnish Swedish
|
|
SPC
|
Itsehoito
|
Moxalole jauhe oraaliliuosta varten PL 2022-10-12
|
|
SPC
|
Resepti
|
Moxifloxacin Fresenius Kabi 400 mg-250 ml infuusioneste, liuos FFX PL 2024-04-24
|
|
SPC
|
Resepti
|
Moxifloxacin Fresenius Kabi 400 mg-250 ml infuusioneste, liuos KabiPac PL 2024-04-24
|
|
SPC
|
Resepti
|
Moxifloxacin Krka 400 mg tabletti, kalvopäällysteinen PL 2024-04-17
|
|
SPC
|
Resepti
|
Moxifloxacin Krka 400 mg-250 ml infuusioneste, liuos PL 2024-04-18
|
|
SPC
|
Resepti
|
Moxifloxacin Orion 400 mg tabletti, kalvopäällysteinen PL 2024-04-28
|
|
SPC
|
Resepti
|
Moxifloxacin Orion 400 mg-250 ml infusioneste, liuos PL 2024-04-28
|
|
SPC
|
Resepti
|
Moxifloxacin SanoSwiss 400 mg tabletti, kalvopäällysteinen PL 2024-03-28
|
|
SPC
|
Resepti
|
Moxifloxacin Stada 400 mg tabletti, kalvopäällysteinen PL 2024-04-26
|
|
SPC
|
Resepti
|
Moxonidin ratiopharm 0.2 mg, 0.4 mg tabletti, kalvopäällysteinen PL 2023-05-05
|
|
SPC
|
Resepti
|
Moxonidin Stada 0,2mg ja 0,4mg tabletti, kalvopäällysteinen PL 2024-04-08
|
|
|
|
European Medicines Agency's website:
Mozobil - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
mRESVIA - EMA: EPAR PI
Finnish Swedish
|
|
SPC
|
Itsehoito
|
Mucomyst 200 mg poretabletti PL OTC 2021-11-15
|
|
SPC
|
Itsehoito
|
Mucoratio 200 mg poretabletti PL 2024-03-22
|
|
SPC
|
Itsehoito
|
Mucoratio 600 mg poretabletti PL OTC 2024-03-22
|
|
SPC
|
Resepti
|
Mucoratio 600 mg poretabletti PL Rx 2024-04-18
|
|
|
|
European Medicines Agency's website:
Multaq - EMA: EPAR PI
Finnish Swedish
|
|
SPC
|
Resepti
|
Multibic 2 mmol/L kalium hemodialyysi-/hemofiltraationeste PIL 2018-02-12
|
|
SPC
|
Resepti
|
Multibic 3 mmol/L kalium hemodialyysi-/hemofiltraationeste PIL 2018-02-12
|
|
SPC
|
Resepti
|
Multibic 4 mmol/L kalium hemodialyysi-/hemofiltraationeste PIL 2018-02-12
|
|
SPC
|
Resepti
|
Multibic kaliumvapaa hemodialyysi-/hemofiltraationeste PIL 2018-02-12
|
|
SPC
|
Resepti
|
Multihance 334 mg, injektioneste, liuos, esitäytetty ruisku, PL 2024-05-09
|
|
SPC
|
Resepti
|
Multihance 334 mg/ml injektioneste, liuos, PL 2024-05-09
|
|
SPC
|
Resepti
|
Muse 125, 250, 500 ja 1000 mikrog virtsatiepuikko PL 2022-04-22
|
|
SPC
|
Resepti
|
Mutaflor 2.5-25x10³x10³x10³ CFU enterokapseli, kova PL 2015-06-05
|
|
SPC
|
Resepti
|
Mutaflor oraalisuspensio PL 2021-03-30.doc
|
|
|
|
European Medicines Agency's website:
Mvabea - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Mvasi - EMA: EPAR PI
Finnish Swedish
|
|
|
| |